Cinacalcet to control mineral metabolism “reasonably” cost effective News item 02 February 2013 Pages: 1 - 1
Functional status affects rheumatic disorders cost in Germany Clinical study 02 February 2013 Pages: 3 - 3
Majority of recommended drugs achieve timely PBS listing Clinical study 02 February 2013 Pages: 3 - 3
ICD therapy economically attractive in patients with stable HF Clinical study 02 February 2013 Pages: 4 - 4
Stepped care for depression more effective, marginally expensive Clinical study 02 February 2013 Pages: 4 - 4
Treatment with long-acting risperidone injection is not associated with reductions in hospital stay or resource use, Clinical study 02 February 2013 Pages: 5 - 5
AdvanDx Inc has announced that the use of its PNA FISH* test for same day identification and reporting of Candida albicans from positive blood cultures Media release 02 February 2013 Pages: 5 - 5
Except in elderly and patients with previous hospitalisations, psychiatric service use showed no increase in adult Israelis, but the use of other health services increased after the onset of insurrection, Clinical study 02 February 2013 Pages: 7 - 7
Meningococcal disease: substantial economic impact in US Clinical study 02 February 2013 Pages: 7 - 7
According to a retrospective analysis of 284 patients with multiple sclerosis (MS), the use of glatiramer acetate reduces the number of work days missed Media release 02 February 2013 Pages: 7 - 7
According to the National Immunization Survey, the vaccination coverage for US children aged 19−35 months remains high, at 76%, Media release 02 February 2013 Pages: 7 - 7
Omega-3 ethylester concentrate saves costs in the long run Clinical study 02 February 2013 Pages: 8 - 8
Pramipexole to treat restless legs syndrome (RLS) results in QOL improvements that remain at 1 year, Clinical study 02 February 2013 Pages: 9 - 9
The rate and adequacy of mental health service use in Mexico is poor, Clinical study 02 February 2013 Pages: 9 - 9
The French government plans to raise funds for HIV/AIDS, tuberculosis and malaria treatment in developing countries by taxing airfares, News item 02 February 2013 Pages: 10 - 10
Drugs to treat Alzheimer's, pain, diabetes show growth potential Clinical study 02 February 2013 Pages: 10 - 10
US pharmaceutical sales growth could slow by almost 1% for 2006, due to the launch of a generic version of clopidogrel [Plavix], News item 02 February 2013 Pages: 11 - 11
Pfizer has announced it will commit $US15 million in an effort to help close critical gaps in malaria treatment Media release 02 February 2013 Pages: 11 - 11
Merck & Co and the Nicaraguan Ministry of Health have announced they are to conduct a new joint project in which Merck will provide free its oral rotavirus vaccine [Rotateq] Media release 02 February 2013 Pages: 11 - 11
Pharmac, New Zealand's drug subsidy agency, has announced that it is to subsidise clopidogrel Media release 02 February 2013 Pages: 11 - 11